These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 16814207)
1. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Jiang Z; Chu PG; Woda BA; Rock KL; Liu Q; Hsieh CC; Li C; Chen W; Duan HO; McDougal S; Wu CL Lancet Oncol; 2006 Jul; 7(7):556-64. PubMed ID: 16814207 [TBL] [Abstract][Full Text] [Related]
2. External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma. Hoffmann NE; Sheinin Y; Lohse CM; Parker AS; Leibovich BC; Jiang Z; Kwon ED Cancer; 2008 Apr; 112(7):1471-9. PubMed ID: 18260086 [TBL] [Abstract][Full Text] [Related]
3. IMP3 predicts aggressive superficial urothelial carcinoma of the bladder. Sitnikova L; Mendese G; Liu Q; Woda BA; Lu D; Dresser K; Mohanty S; Rock KL; Jiang Z Clin Cancer Res; 2008 Mar; 14(6):1701-6. PubMed ID: 18347170 [TBL] [Abstract][Full Text] [Related]
4. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis. Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661 [TBL] [Abstract][Full Text] [Related]
5. Combination of quantitative IMP3 and tumor stage: a new system to predict metastasis for patients with localized renal cell carcinomas. Jiang Z; Chu PG; Woda BA; Liu Q; Balaji KC; Rock KL; Wu CL Clin Cancer Res; 2008 Sep; 14(17):5579-84. PubMed ID: 18765551 [TBL] [Abstract][Full Text] [Related]
6. Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas. Jiang Z; Lohse CM; Chu PG; Wu CL; Woda BA; Rock KL; Kwon ED Cancer; 2008 Jun; 112(12):2676-82. PubMed ID: 18412154 [TBL] [Abstract][Full Text] [Related]
7. Enhanced IMP3 Expression Activates NF-кB Pathway and Promotes Renal Cell Carcinoma Progression. Pei X; Li M; Zhan J; Yu Y; Wei X; Guan L; Aydin H; Elson P; Zhou M; He H; Zhang H PLoS One; 2015; 10(4):e0124338. PubMed ID: 25919292 [TBL] [Abstract][Full Text] [Related]
8. Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinoma. Tschirdewahn S; Panic A; Püllen L; Harke NN; Hadaschik B; Riesz P; Horváth A; Szalontai J; Nyirády P; Baba HA; Reis H; Szarvas T Int J Cancer; 2019 Jul; 145(2):531-539. PubMed ID: 30650187 [TBL] [Abstract][Full Text] [Related]
9. The oncofetal protein IMP3: a novel molecular marker to predict aggressive meningioma. Hao S; Smith TW; Chu PG; Liu Q; Ok CY; Woda BA; Lu D; Lin P; Wang SA; Dresser K; Rock KL; Jiang Z Arch Pathol Lab Med; 2011 Aug; 135(8):1032-6. PubMed ID: 21809995 [TBL] [Abstract][Full Text] [Related]
10. The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma. Erdem S; Yegen G; Telci D; Yildiz I; Tefik T; Issever H; Kilicaslan I; Sanli O World J Urol; 2015 Oct; 33(10):1553-60. PubMed ID: 25515319 [TBL] [Abstract][Full Text] [Related]
11. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Jeng YM; Chang CC; Hu FC; Chou HY; Kao HL; Wang TH; Hsu HC Hepatology; 2008 Oct; 48(4):1118-27. PubMed ID: 18802962 [TBL] [Abstract][Full Text] [Related]
12. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680 [TBL] [Abstract][Full Text] [Related]
13. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177 [TBL] [Abstract][Full Text] [Related]
14. IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma. Li HG; Han JJ; Huang ZQ; Wang L; Chen WL; Shen XM J Craniofac Surg; 2011 Nov; 22(6):2022-5. PubMed ID: 22067851 [TBL] [Abstract][Full Text] [Related]
15. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma. Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tissue and circulating levels of IMP3 in prostate cancer. Szarvas T; Tschirdewahn S; Niedworok C; Kramer G; Sevcenco S; Reis H; Shariat SF; Rübben H; vom Dorp F Int J Cancer; 2014 Oct; 135(7):1596-604. PubMed ID: 24615121 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma. Yu ZH; Zhang Q; Wang YD; Chen J; Jiang ZM; Shi M; Guo X; Qin J; Cui GH; Cai ZM; Gui YT; Lai YQ Asian Pac J Cancer Prev; 2013; 14(6):3729-34. PubMed ID: 23886173 [TBL] [Abstract][Full Text] [Related]
19. mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance. Rausch S; Schollenberger D; Hennenlotter J; Stühler V; Kruck S; Stenzl A; Bedke J J Cancer Res Clin Oncol; 2019 Jan; 145(1):153-163. PubMed ID: 30368665 [TBL] [Abstract][Full Text] [Related]
20. IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma. Yan J; Wei Q; Jian W; Qiu B; Wen J; Liu J; Fu B; Zhou X; Zhao T Lung; 2016 Feb; 194(1):137-46. PubMed ID: 26608347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]